Latest Applied genetics Stories
Defects in the genome are the cause of many diseases.
CARLSBAD, Calif., Jan. 10, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that it will hold a conference call focused on Genzyme's recent regulatory discussions with the FDA about the mipomersen NDA filing.
AMSTERDAM, January 10, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced today that it has entered into an agreement with Institut Pasteur, Paris, France, and a group of French research institutes (together the "Consortium") to support clinical development of a novel gene therapy to treat Sanfilippo B. This rare genetic disease affecting new-born children leads to progressive neuronal degeneration and death.
A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials.
Why wonder when you can get results now at Any Lab Test Now® Atlanta, GA (Vocus/PRWEB) January 03, 2011 With out of wedlock birth rates in the US on the rise Any Lab Test Now® offers legally-admissible paternity tests that can be used in a court of law.
Dr Alex Bronstein of Tel Aviv University's Department of Electrical Engineering has a new way to stop video pirates.
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College London) to correct the inherited bleeding disorder.
AMSTERDAM, December 2, 2010 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) Holding N.V.
Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics 60th Annual Meeting, which will be held November 2-6, 2010, in Washington, D.C.
FORT LEE, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Neurologix, Inc.
- To swell, as grain or wood with water.